Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1977 2
1999 1
2008 1
2009 2
2010 1
2011 4
2012 4
2013 3
2014 1
2015 1
2016 3
2017 4
2018 2
2019 7
2020 10
2021 3
2022 6
2023 6
2024 12
2025 8
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Rifampicin-resistant tuberculosis in Spain.
García-García JM, Rodrigo-Sanz T, Gullón-Blanco JA, Casas García X, Millet JP, Quirós Fernández S, Martínez Lirola MJ, Mangas Moro A, Domínguez Castellano Á, Navas Elorza E, Nieto Marcos M, Arasa Panisello F, Bermúdez Ruiz P, García Cabrera M, Sanz Herrero F, Suárez Toste I, Urrelo Cerrón LA, Espiau Guarner M, Soriano Arandes A, Arias Guillén M, Cebrián Gallardo JJ, García-Fuertes JA, Pérez-Jacoiste Asín MA, Somoza González M, Palacios Gutiérrez JJ, Alcaide F, Samper Blasco S, Tabernero Huguet E, Caylà JA, Ruiz Manzano J, Caminero Luna JA; Working Group on Rifampicin Resistant Tuberculosis of the Tuberculosis Research Programme (PII-TB) SEPAR. García-García JM, et al. Among authors: millet jp. ERJ Open Res. 2026 Feb 23;12(1):00941-2025. doi: 10.1183/23120541.00941-2025. eCollection 2026 Jan. ERJ Open Res. 2026. PMID: 41736728 Free PMC article.
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS; TB Trials Consortium iAdhere Study Team. Belknap R, et al. Among authors: millet jp. Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7. Ann Intern Med. 2017. PMID: 29114781 Free PMC article. Clinical Trial.
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.
Diab Casares L, Espinosa Pereiro J, Tórtola Fernández MT, Casas García X, Millet JP, Pomar Solchaga V, Navas Elorza E, Troya García J, Díaz de Santiago A, Luque Márquez R, Medina Gallardo JF, González Galán V, Montero Alonso M, Gil Brusola A, Rabuñal Rey R, Anibarro García L, Sanz Herrero F, Guna Serrano R, Garrigó Fullola M, Tato Díez M, Talavan Zanón T, Portero MF, Alonso García P, Saez López AM, Aznar ML, Martínez Campreciós J, Saborit N, Sánchez Montalvá A. Diab Casares L, et al. Among authors: millet jp. BMJ Open Respir Res. 2025 Dec 7;12(1):e002475. doi: 10.1136/bmjresp-2024-002475. BMJ Open Respir Res. 2025. PMID: 41360613 Free PMC article.
Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.
Caminero JA, Anibarro L, Tabernero E, Alcaide F, Pérez-Mendoza G, Millet JP, Guna R, de Souza-Galvão ML, López-Roa P, Sánchez-Montalvá A, Gullón-Blanco JA, González-Galán V. Caminero JA, et al. Among authors: millet jp. Arch Bronconeumol. 2026 Jun;62(6):387-399. doi: 10.1016/j.arbres.2025.10.021. Epub 2026 Jan 15. Arch Bronconeumol. 2026. PMID: 41545280 English, Spanish.
Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.
Caminero JA, Anibarro L, Tabernero E, Alcaide F, Pérez-Mendoza G, Millet JP, Guna R, de Souza-Galvão ML, López-Roa P, Sánchez-Montalvá A, Gullón-Blanco JA, González-Galán V. Caminero JA, et al. Among authors: millet jp. Enferm Infecc Microbiol Clin (Engl Ed). 2026 Jun-Jul;44(6):503037. doi: 10.1016/j.eimce.2025.503037. Enferm Infecc Microbiol Clin (Engl Ed). 2026. PMID: 42264591
Clostridium and Cryptosporidium outbreak linked to a splash pad.
de Andrés Aguayo A, Millet JP, Álvarez-Bruned L, Palma D, Gómez A, Gallés P, Sabaté S, Álvarez G, Rodriguez V, Cornejo T, Rius C. de Andrés Aguayo A, et al. Among authors: millet jp. BMC Public Health. 2024 Jun 12;24(1):1578. doi: 10.1186/s12889-024-18870-7. BMC Public Health. 2024. PMID: 38867266 Free PMC article.
Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis.
Villar-Hernández R, Latorre I, Noguera-Julian A, Martínez-Planas A, Minguell L, Vallmanya T, Méndez M, Soriano-Arandes A, Baquero-Artigao F, Rodríguez-Molino P, Guillén-Martín S, Toro-Rueda C, De Souza-Galvão ML, Jiménez-Fuentes MÁ, Stojanovic Z, Sabriá J, Santos JR, Puig J, Domínguez-Álvarez M, Millet JP, Altet N, Galea Y, Muriel-Moreno B, García-García E, Bach-Griera M, Prat-Aymerich C, Julián E, Torrelles JB, Rodrigo C, Domínguez J. Villar-Hernández R, et al. Among authors: millet jp. Pediatr Infect Dis J. 2024 Mar 1;43(3):278-285. doi: 10.1097/INF.0000000000004211. Epub 2023 Dec 18. Pediatr Infect Dis J. 2024. PMID: 38113520 Free article.
Impact of the COVID-19 pandemic on contact tracing of patients with pulmonary tuberculosis.
Godoy P, Parrón I, Barrabeig I, Caylà JA, Clotet L, Follia N, Carol M, Orcau A, Alsedà M, Ferrús G, Plans P, Jane M, Millet JP, Domínguez A; Transmission of Tuberculosis in Catalonia (Spain) Working Group. Godoy P, et al. Among authors: millet jp. Eur J Public Health. 2022 Aug 1;32(4):643-647. doi: 10.1093/eurpub/ckac031. Eur J Public Health. 2022. PMID: 35325093 Free PMC article.
86 results